Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Beleave Inc (BLEVF)
OTHER OTC:BLEVF
Beleave (BLEVF) Stock Price & Analysis
51 Followers
BLEVF Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Options Prices
Currently, No data available
---
Ownership Overview
11.83%
Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
88.17% Public Companies and
Individual Investors
BLEVF FAQ
What was Beleave Inc’s price range in the past 12 months?
Currently, no data Available
What is Beleave Inc’s market cap?
Currently, no data Available
When is Beleave Inc’s upcoming earnings report date?
Beleave Inc’s upcoming earnings report date is Mar 03, 2020 which is 1600 days ago.
How were Beleave Inc’s earnings last quarter?
Beleave Inc released its earnings results on Nov 29, 2019. The company reported -$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.004.
Is Beleave Inc overvalued?
According to Wall Street analysts Beleave Inc’s price is currently Overvalued.
Does Beleave Inc pay dividends?
Beleave Inc does not currently pay dividends.
What is Beleave Inc’s EPS estimate?
Beleave Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Beleave Inc have?
Beleave Inc has 566,368,650 shares outstanding.
What happened to Beleave Inc’s price movement after its last earnings report?
Beleave Inc reported an EPS of -$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Beleave Inc?
Currently, no hedge funds are holding shares in BLEVF
---
Company Description
Beleave Inc
Beleave, Inc. engages in the cultivation, production, and sale of cannabis products. It operates through the Cannabis Products and Patient Network segments. The Cannabis Products segment is involved in the provision of marijuana for medical purposes. The Patient Network segment delivers medical cannabis services. The company was founded by Vasilios Panagiotakopoulos and Justin Kosalka on May 26, 2000 and is headquartered in Oakville, Canada.
---
---